Content Section

PET for Cancer Trials

Additionally, in a National Coverage Determination for PET (FDG) for All Other Cancer Indications Not Previously Specified (220.6.15) the Centers for Medicare & Medicaid Services (CMS) determined that the evidence is sufficient to conclude that an FDG PET scan is reasonable and necessary only when the provider is participating in, and patients are enrolled in a prospective clinical studies that is designed to collect additional information at the time of the scan to assist in patient management.

  There are 2 items in this list.

Sort by: Facility name Ascending Facility name Descending Provider Number Ascending Provider Number Descending Date Approved Ascending Date Approved Descending State Ascending State Descending

View Results in Excel

Facility name	Provider Number	Date Approved	State
The Southwest Oncology Group (SWOG) and the American College of Radiology Imaging Network (ACRIN)	N/A	08/01/2007	ALABAMA
The Cleveland Clinic Taussig Cancer Center	34-0714585	08/17/2007	OHIO

View Items Per Page:102030All

Data Last Updated : 08/12/2008
Help with File Formats and Plug-Ins

Submit Feedback